PATENT CLAIM ANALYSIS

Application Number: 16243205
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "010300"]

Abstract:
The present invention relates to an abuse-proofed oral dosage form with controlled release of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol for once daily administration, which comprises the active ingredient and/or one or more of the pharmaceutically acceptable salts thereof (A), at least one synthetic or natural polymer (C), delayed-release auxiliary substances, optionally physiologically acceptable auxiliary substances (B) and optionally a wax (D), component (C) or (D) in each case exhibiting a breaking strength of at least 500 N, preferably of at least 1000 N.

Claim (Index 5):
A dosage form according to  claim 4 , wherein the polyethylene oxide is of high molecular weight.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 99.0
- Lexical Diversity: 1.56716
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10718112', '11349544', '13270505', '15265263', '13346257']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7189273877910171
- 35 USC 102 Novelty (BERT): 0.4990763256291036
- Combined Prediction Score: 0.6969422815748256
- Mean Citation Score: 186.970304
- Max Citation Score: 202.11156
- Similarity Product: 134.176796571486

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test